These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2159831)

  • 1. MK801 prevents quinolinic acid-induced behavioral deficits and neurotoxicity in the striatum.
    Giordano M; Ford LM; Brauckmann JL; Norman AB; Sanberg PR
    Brain Res Bull; 1990 Mar; 24(3):313-9. PubMed ID: 2159831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats.
    Vezzani A; Serafini R; Stasi MA; Caccia S; Conti I; Tridico RV; Samanin R
    J Pharmacol Exp Ther; 1989 Apr; 249(1):278-83. PubMed ID: 2540317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neural grafts and pharmacological intervention in a model of Huntington's disease.
    Giordano M; Ford LM; Shipley MT; Sanberg PR
    Brain Res Bull; 1990 Sep; 25(3):453-65. PubMed ID: 1963345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMDA preconditioning protects against seizures and hippocampal neurotoxicity induced by quinolinic acid in mice.
    Boeck CR; Ganzella M; Lottermann A; Vendite D
    Epilepsia; 2004 Jul; 45(7):745-50. PubMed ID: 15230696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum.
    Engber TM; Chase TN
    Neurosci Lett; 1988 Dec; 95(1-3):269-74. PubMed ID: 2976130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic approaches to modifying quinolinic acid striatal lesions in rats.
    Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
    J Neurosci; 1988 Oct; 8(10):3901-8. PubMed ID: 2461437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist.
    Fariello RG; Golden GT; Smith GG; Reyes PF
    Epilepsy Res; 1989; 3(3):206-13. PubMed ID: 2543557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinate.
    Zhu SG; McGeer EG; McGeer PL
    Brain Res; 1989 Mar; 481(2):356-60. PubMed ID: 2524238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female rats are more sensitive to the locomotor alterations following quinolinic acid-induced striatal lesions: effects of striatal transplants.
    Emerich DF; Zubricki EM; Shipley MT; Norman AB; Sanberg PR
    Exp Neurol; 1991 Mar; 111(3):369-78. PubMed ID: 1847880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum.
    Norman AB; Ford LM; Sanberg PR
    Exp Neurol; 1991 Oct; 114(1):132-5. PubMed ID: 1680744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors in rat striatum.
    Norman AB; Ford LM; Kolmonpunporn M; Sanberg PR
    Eur J Pharmacol; 1990 Feb; 176(3):363-6. PubMed ID: 2139415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats.
    Pierozan P; Zamoner A; Soska AK; Silvestrin RB; Loureiro SO; Heimfarth L; Mello e Souza T; Wajner M; Pessoa-Pureur R
    Exp Neurol; 2010 Jul; 224(1):188-96. PubMed ID: 20303347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
    Schmidt WJ; Bubser M
    Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity induced by continuous infusion of quinolinic acid into the lateral ventricle in rats.
    Yamada K; Fuji K; Nabeshima T; Kameyama T
    Neurosci Lett; 1990 Oct; 118(1):128-31. PubMed ID: 2147984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between GABAergic anticonvulsants and the NMDA receptor antagonist MK 801 against MES- and picrotoxin-induced convulsions in rats.
    Kulkarni SK; Ticku MK
    Life Sci; 1989; 44(18):1317-23. PubMed ID: 2541293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The topography of MK-801-induced locomotor patterns in rats.
    Ford LM; Norman AB; Sanberg PR
    Physiol Behav; 1989 Oct; 46(4):755-8. PubMed ID: 2557649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK801-induced antagonism of NMDA-preferring excitatory amino acid receptors in horizontal cells of the turtle retina.
    Anderton PJ; Millar TJ
    Neurosci Lett; 1989 Jul; 101(3):331-6. PubMed ID: 2549465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice.
    Carlsson M; Carlsson A
    J Neural Transm; 1989; 75(3):221-6. PubMed ID: 2538557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative behavioral and neurochemical studies with striatal kainic acid- or quinolinic acid-lesioned rats.
    Vécsei L; Beal MF
    Pharmacol Biochem Behav; 1991 Jun; 39(2):473-8. PubMed ID: 1719569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
    Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
    Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.